Skip to main content
. 2020 Mar 11;13(3):44. doi: 10.3390/ph13030044

Figure 5.

Figure 5

Cytotoxicity effects (IC50) of cisplatin-loaded PBCA nanoparticles (19.2 ± 0.41, 17 ± 0.9 and 15 ± 0.27 µM after 24-, 48- and 72-h incubation, respectively) compared to the standard drug (44.4 ± 1.9, 26 ± 0.83, and 20.3 ± 0.22 µM after 24-, 48-, and 72-h incubation, respectively) against human renal adenocarcinoma (ACHN). The data were expressed as mean ± SD (n = 3).